REPLIGEN CORP Accounts Payable, Related Parties, Current
REPLIGEN CORP (RGEN) had Accounts Payable, Related Parties, Current of $1.73 million as of 2018-09-30, per its 10-Q filed 2018-11-01.
Discontinued › Notes › Payables and Accruals
us-gaap:AccountsPayableRelatedPartiesCurrent · last filed 2018-11-01
- 2018-09-30: Accounts Payable, Related Parties, Current $1.73M.
| Period end | Accounts Payable, Related Parties, Current |
|---|---|
| 2018-09-30 | $1.73M 10-Q · filed 2018-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |